Skip to main content
ConductScienceScienceDex
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

6,569

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

6,569 results for “Long-term”

Learn how ShareScore rates datasets ↗
zenodo12/100

Dataset related to article "Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical Prognosis"

<p>This record contains raw data related to article "Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical Prognosis"</p><p><strong>Abstract</strong></p><p><strong>Background: </strong>Breast cancer (BC) is very uncommon in young women (YW) and it is unclear whether a BRCA mutation has prognostic implications. Our aim was to evaluate the characteristics of YW with BC by comparing the long-term oncological results between BRCA-mutation carriers and non-carriers.</p><p><strong>Methods: </strong>We retrospectively reviewed all the consecutive YW (aged 18-40 years) diagnosed with BC. Endpoints were disease-free survival (DFS), distant disease-free survival (DDFS), and overall survival (OS).</p><p><strong>Results: </strong>63 YW with a BRCA mutation were compared with 339 YW without BRCA mutation. BRCA-mutation carriers were younger (60.3% versus 34.8% if age ≤ 35 years, <i>p</i> = 0.001) and presented with more aggressive tumors (66.7% versus 40.7% if G3, <i>p</i> = 0.001; 57.2% versus 12.4% if biological subtype triple-negative, <i>p</i> = 0.001; 73.0% versus 39.2% if Ki67 ≥ 25%, <i>p</i> = 0.001). Non-carriers presented significantly better DFS, DDFS, and OS compared with BRCA-mutation carriers. Neoadjuvant chemotherapy was found to be an independent protective factor for OS in BRCA-mutation carriers.</p><p><strong>Conclusions: </strong>BC is more likely to present at a younger age (≤ 35 years) and with more aggressive characteristics (G3, triple-negative, Ki67 ≥ 25%) in YW with BRCA mutation compared with their non-mutated counterparts. Young BRCA-mutation carriers showed a poorer prognosis in terms of recurrence and survival compared with non-carriers. The implementation of neoadjuvant chemotherapy may improve survival in YW with BC and BRCA mutation.</p>

restrictedNov 2023View details →
zenodo12/100

EJP SOIL C-arouNd - (Meta)data of Long-term field experiments (LET)

Open the record for dataset details and reuse information.

embargoedcc-by-4.0Apr 2024View details →
zenodo12/100

Long-term Histological Evaluation of a Novel Dermal Template in the Treatment of Paediatric Burns

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Nov 2024View details →
zenodo12/100

Data Set_Urinary Albumin-to-Creatinine Ratio as an Independent Predictor of Long-term Mortality in Atherosclerotic Cardiovascular Disease Patients: A Propensity Score-Matched Study

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Nov 2024View details →
zenodo12/100

Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with Hypertrophic Cardiomyopathy

<p>Dataset associated with paper "Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with Hypertrophic Cardiomyopathy"</p> <p><strong>This set of raw data is accessible under request because include sensitive information. Please write your request at l.crotti@auxologico.it</strong></p>

restrictedJul 2024View details →
zenodo12/100

Video S2 Five-year monitoring of a desert burrow-dwelling spider fol-lowing an environmental disaster indicates long-term impacts.

<p>A supplementary video S2</p> <p><em>Sahastata aravaensis</em> sp. nov. feeding in captivity with ants, Efrat Gavish-Regev. The spiders usually bite the ant&rsquo;s leg before feeding.</p> <p>Five-year monitoring of a desert burrow-dwelling spider fol-lowing an environmental disaster indicates long-term impacts.</p> <p>Submitted to the Journal: Insects</p> <p>&nbsp;</p>

restrictedOct 2021View details →
zenodo12/100

Long-term follow-up after recanalisation of aortic arch atresia.

<p>Dataset from&nbsp;Chessa M, Favoccia C, Jha NK, Carminati M, Fernandez Gonzalez L, Eicken A, Butera G, Ferreira Martins JD, Pinto F, Tofeig M, Khan MD. Long-term follow-up after recanalisation of aortic arch atresia. EuroIntervention. 2021 Feb 5;16(15):e1274-e1280. doi: 10.4244/EIJ-D-18-00857. PMID: 31235456.</p> <p>Abstract</p> <p><strong>Aims:&nbsp;</strong>Aortic arch atresia (AAA) is one of the rarest obstructive defects. The presence of this anomaly in adult age is uncommon. The typical anatomic feature consists of a complete occlusion of the membranous obstruction resulting in an acquired atresia without flow continuity between the proximal and distal segments. This feature is important in determining the feasibility of percutaneous intervention. The aim of the present study was to share long-term follow-up data of adult patients with AAA requiring percutaneous interventions for the management of this rare anomaly involving five different centres.</p> <p><strong>Methods and results:&nbsp;</strong>Retrospective data of 19 patients (12 males, 63.2%, mean age 32.2&plusmn;18.9 years) diagnosed with AAA treated in five different centres between 1999 and 2017 were collected. All patients underwent percutaneous recanalisation by (1) radiofrequency (RF) system (five patients, 26.3%), (2) extra-stiff guidewire (12 patients, 63.2%), and (3) transseptal needle (two patients, 10.5%). All procedures were subsequently followed by covered stent implantation. Two patients developed complications during the procedure and one of them died. Over a median follow-up of 4.94 years, four (21%) patients were able to be weaned from medications for hypertension. All the patients underwent reassessment for recurrence or restenosis during the follow-up. Seven (36.8%) patients underwent successful stent dilatation with a balloon. After the intervention, one patient experienced a late complication; however, one patient died due to an unknown cause believed to be unrelated to the previous recanalisation procedure.</p> <p><strong>Conclusions:&nbsp;</strong>Percutaneous treatment of AAA is feasible with good long-term survival. This study reports the largest case series so far available in the literature.</p>

restrictedJan 2022View details →
zenodo12/100

Dataset related to the article "Persistent long-term platelet activation and endothelial perturbation in women with Takotsubo syndrome"

<p>This record contains raw data related to the article &quot;Persistent long-term platelet activation and endothelial perturbation in women with Takotsubo syndrome&quot;</p> <p><strong>Background:&nbsp;</strong>Takotsubo (TTS) syndrome is an acute cardiac condition characterized by transient and reversible left ventricle dysfunction that mainly affects postmenopausal women. Catecholamine burst is the most accredited mechanism underpinning TTS onset and leading to endothelial dysfunction and platelet activation. Even if the use of low dose acetylsalycilic acid (ASA) in this clinical setting is based on both clinical presentation and unfavorable long-term prognosis, its efficacy has been recently challenged.</p> <p><strong>Aim:&nbsp;</strong>This study was designed to assess endothelial function, residual thromboxane formation and platelet aggregation in TTS women on low-dose ASA treatment at long-term follow-up.</p> <p><strong>Methods:&nbsp;</strong>Twenty-eight females with previously diagnosis of TTS syndrome were enrolled. Data were compared to those obtained from 23 coronary artery disease (CAD) women with a history of acute myocardial infarction, and 26 control subjects with no TTS or clinically evident CAD. Psychological and clinical profile were assessed in all study groups at the enrollment. Main metabolites involved in L-arginine/nitric oxide pathway, urinary prostacyclin, serum and urine thromboxane metabolites were measured by LCMS/MS methods. Thrombomodulin levels were quantified using an ELISA kit, and platelet aggregation, carried out on platelet rich-plasma, was induced by ADP or by epinephrine (EPI), norepinephrine (NORE) and TRAP-6, alone or in association with ADP and evaluated by Born&#39;s method.</p> <p><strong>Results:&nbsp;</strong>In TTS women an endothelial derangement, characterized by reduced citrulline production and increased thrombomodulin concentration, with no perturbation in prostacyclin levels, was evidenced. In addition, despite ASA treatment, TTS displayed a higher residual thromboxane formation, in parallel with an enhanced platelet response to compared to CAD.</p> <p><strong>Conclusions:&nbsp;</strong>Our study highlighted the presence of endothelial perturbation in TTS patients even at long-term from the index event. The residual thromboxane production and platelet aggregation still leave open the question about the use of low dose ASA in this clinical setting.</p>

restrictedJan 2022View details →
zenodo12/100

Dataset related to article "Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer"

<p>This record contains raw data related to article &ldquo;Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer&quot;</p> <p>Because the risk of relapse of node-negative breast cancer (BC) is largely varying, we evaluated the prognosis of a cohort of 1276 patients with this disease and the factors associated with increased risk of relapse. Overall, in nodenegative BC, age, hormonal receptor status, tumor size, and Ki67 were prognostic factors. The triple-negative BC subtype was not associated with a poorer prognosis compared with the human epidermal growth factor receptor 2-positive subtype, but showed a worse overall survival compared with luminal-like BC. Background: Because the risk of relapse of node-negative breast cancer (BC) is varying, we evaluated the prognosis of patients with this disease and the factors associated with increased risk of relapse. Patients and Methods: The clinical charts of patients with BC with evidence of negative nodes and with a potential 5-year follow-up were retrospectively reviewed</p>

restrictedJan 2022View details →
zenodo12/100

Dataset related to article "Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center "

<p>This record contains raw data related to article &ldquo;Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center&quot;</p> <p><strong>Introduction: </strong> Salvage mastectomy is considered the treatment of choice for ipsilateral breast cancer recurrence (IBCR), even if a second breast-conserving surgery (BCS) is feasible. The purpose of this study was to describe the characteristics of IBCR patients, to compare the 2 therapeutic options in terms of long-term outcomes, and to identify independent factors that may predict the type of treatment.</p> <p><strong>Patients and methods: </strong> A total of 309 IBCR patients who underwent either repeat BCS or mastectomy were identified. All the analyzed patients with IBCR had true recurrence.</p> <p><strong>Results: </strong> Repeat BCS and salvage mastectomy were performed in 143 and 166 patients, respectively. Age &lt; 65 years (59.6% vs 37.1% if age &ge; 65 years; odds ratio, 2.374; 95% confidence interval, 0.92-5.24; P = .018) and disease-free interval &lt; 24 months (15.7% vs 10.5% if disease-free interval &ge; 24 months; odds ratio, 2.705; 95% confidence interval, 1.42-5.97; P = .007) were found to significantly increase the probability of receipt of mastectomy. Disease-free survival rates at 3, 5, and 10 years were 79.2%, 68.2%, and 36.9%; and 77.2%, 65.9%, and 55.3% in patients receiving repeat BCS or mastectomy, respectively (P = .842). Overall survival rates at 3, 5, and 10 years were 95.4%, 91.4%, and 68.5%; and 87.3%, 69.3%, and 57.9%, respectively, in patients receiving repeat BCS or mastectomy (P = .018).</p> <p><strong>Conclusion: </strong> Salvage mastectomy should not be considered the only treatment option for IBCR. A second BCS can still be evaluated and proposed to IBCR patients, with acceptable locoregional control and survival. The risk of poor long-term prognosis after mastectomy should be shared with the patient.</p>

restrictedFeb 2022View details →
zenodo12/100

Aortic valve sclerosis as an important predictor of long-term mortality in patients with carotid atheromatous plaque requiring carotid endarterectomy

<p>This record contains raw data related to the article &quot;Aortic valve sclerosis as an important predictor of long-term mortality in patients with carotid atheromatous plaque requiring carotid endarterectomy&quot;.&nbsp;A strong association between aortic valve sclerosis (AVSc), the earliest manifestation of calcific aortic valve disease, and atherosclerosis exists. The aim of the study was to evaluate the predictive capabilities of AVSc on long-term all-cause mortality, in patients requiring carotid endarterectomy (CEA).&nbsp;806 consecutive CEA patients were enrolled. Preoperative echocardiography was used to assess AVSc. Computed tomography angiography was applied for plaque characterization. Kaplan-Meier curves, Cox linear regression, and area under the receiving operator characteristic (AUC) curve analyses were used to evaluate the predictive capability of AVSc. Overall, 348 of 541 patients had AVSc (64%). Age, diabetes, and estimated glomerular filtration rate (eGFR) were associated with AVSc. In the 5-year follow-up, AVSc group had a mortality rate of 16.7% while in no-AVSc group was 7.8%. Independent predictors of all-cause mortality were age, sex, eGFR, left ventricular ejection fraction, and AVSc. After adjustments, AVSc was associated with a significant increase in all-cause mortality risk (hazard ratio, HR = 1.9; 95%CI: 1.04-3.54;&nbsp;<em>p</em>&nbsp;= 0.038). We stratify our cohort based on carotid atheromatous plaque-type: soft, calcified, and mixed-fibrotic. In patients with mixed-fibrotic plaques, the mortality rate of AVSc patients was 15.5% compared to 2.4% in no-AVSc patients. In this group, AVSc was associated with an increased long-term all-cause mortality risk with an adjusted HR of 12.8 (95%CI: 1.71-96.35;&nbsp;<em>p</em>&nbsp;= 0.013), and the AUC, combing eGFR and AVSc was 0.77 (<em>p</em>&nbsp;&lt; 0.001).&nbsp;Our findings indicate that AVSc together with eGFR may be used to improve long-term risk stratification of patients undergoing CEA surgery.</p>

restrictedFeb 2022View details →
zenodo12/100

Dataset related to the article "Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach"

<p>This record contains raw data related to the article &quot;Long-Term Outcomes of Near-Zero Radiation Ablation of Paroxysmal Supraventricular Tachycardia: A Comparison With Fluoroscopy-Guided Approach&quot;.</p> <p>&nbsp;</p> <p><em><strong>Abstract</strong></em></p> <p><strong>Objectives:&nbsp;</strong>This study aimed to assess the long-term outcomes of minimally fluoroscopic approach (MFA) compared with conventional fluoroscopic ablation (ConvA) in terms of recurrences of arrhythmia and long-term complications.</p> <p><strong>Background:&nbsp;</strong>Catheter ablation (CA) of supraventricular tachycardia (SVT) with an MFA, under the guidance of electroanatomic mapping (EAM) systems, results in a significant reduction in exposure to ionizing radiations without impairing acute procedural success and complication rate. However, data regarding long-term outcomes of MFA compared with ConvA are lacking.</p> <p><strong>Methods:&nbsp;</strong>This is a retrospective observational study. All patients undergoing MFA CA of SVT (atrioventricular nodal re-entrant tachycardia and atrioventricular re-entrant tachycardia) between 2010 and 2015 were enrolled and were compared with matched subjects (1 MFA: 2 ConvA) undergoing ConvA during the same period. The 2 co-primary outcomes were recurrence of arrhythmias and long-term complications.</p> <p><strong>Results:&nbsp;</strong>A total of 618 patients (mean age 38 &plusmn; 15 years, 60% female) were enrolled. MFA included 206 patients, whereas 412 were treated with ConvA. Acute success (99% vs. 97%; p = 0.10) and acute complications (2.4% vs. 5.3%; p = 0.14) were similar in the 2 groups. During a median follow-up of 4.4 years, 5.9% of patients experienced recurrence of arrhythmias. At multivariate analysis, ConvA (hazard ratio [HR]: 3.03) and procedural success (HR: 0.10) were independently associated with recurrence of arrhythmias. Late complications (i.e., advance atrioventricular block and need for pacemaker implantation) occurred more frequently in ConvA (3.4% vs. 0.5%; p = 0.03) compared with MFA.</p> <p><strong>Conclusions:&nbsp;</strong>CA guided by EAM systems with MFA provided better long-term results and reduced risk of complications compared with ConvA.</p>

restrictedMar 2022View details →
zenodo12/100

Dataset related to article "Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single center"

<p>This record contains raw data related to article &quot;Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Gu&eacute;rin: experience of a single center&quot;</p> <p>BACKGROUND:</p> <p>To assess the outcomes of patients with high-grade (HG) pT1 bladder cancer (BC) treated with intravesical BCG therapy.</p> <p>METHODS:</p> <p>The study population consisted of 185 patients with HG pT1 BC treated between 1998 and 2010. We aimed to determine recurrence-free (RFS) and progression-free survival (PFS), as well as the predictors of RFS and PFS.</p> <p>RESULTS:</p> <p>Overall, 143 (77.3%) patients were males. Median age was 72 years (IQR: 66-78). Tumor size was &ge;3 cm in 100 (54.1%) individuals. Most patients had single tumors (125; 67.6%). Primary, progressive and recurrent patterns of presentation were observed in 146 (78.9%), 21 (11.4%), and 18 (9.7%) cases, respectively. After 2nd-look TURB, 127 (68.6%) patients had no residual disease, 44 (23.8%) had Ta/CIS, and 14 (7.6%) had T1 HG BC. Twenty-two (11.9%) patients experience early recurrence after BCG. Of these, 12 patients (54.5%) were diagnosed with Ta/CIS, while 10 (45.5%) were diagnosed with HG pT1 BC. The median follow-up was 93 months (IQR: 63-147). Ten-year RFS and PFS rates were 69.6 and 79.2%. In multivariable Cox regression models, female gender (HR=2.41; P=0.001), progressive (HR=2.03; P=0.030) and recurrent (HR=3.87; P&lt;0.001) pattern of presentation emerged as independent predictors of RFS, while age &ge;70 years (HR=2.13; P=0.027), presence of multiple tumors (HR=2.06; P=0.019), and early recurrence (HR=3.88; P&lt;0.001) emerged as independent predictors of PFS.</p> <p>CONCLUSIONS:</p> <p>Intravesical BCG appears to be an effective treatment for HG pT1 BC. Caution should be used in patients aged &ge;70 years, with multiple tumors or experiencing early recurrence.</p>

restrictedSep 2019View details →
zenodo12/100

Bioengineering the metabolic network of CAR T-cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Oct 2024View details →
zenodo12/100

Dataset related to the article "Associations of Preoperative Self-rated Symptoms of Anxiety and Depression on Length of Hospital Stay and Long-term Quality of Life in Patients Undergoing Cardiac Surgery"

<p>This record contains raw data related to the article &quot;Associations of Preoperative Self-rated Symptoms of Anxiety and Depression on Length of Hospital Stay and Long-term Quality of Life in Patients Undergoing Cardiac Surgery&quot;</p> <p><strong>ABSTRACT</strong></p> <p><strong>Background:&nbsp;</strong>Anxiety and depression are often associated with cardiovascular diseases. Nevertheless, few study authors have investigated psychological effects on immediate and long-term cardiac surgery-related outcomes, such as surgical complications, length of hospital stay (LOS), and long-term health-related quality of life (HRQoL).</p> <p><strong>Objectives:&nbsp;</strong>The aims of this study were to (a) investigate the role of preoperative symptoms of anxiety and depression in predicting LOS in a sample of surgical patients and (b) evaluate the impact of preoperative symptoms of anxiety and depression on the patients&#39; HRQoL 3 months after surgery.</p> <p><strong>Methods:&nbsp;</strong>One hundred fifty-one patients waiting for surgery were included. To evaluate symptoms of anxiety and depression, the Hospital Anxiety and Depression Scale was used. Multiple regression analyses were conducted to evaluate the impact of both clinical and psychological factors on LOS, whereas quantile regression was performed to assess their effect on the patients&#39; HRQoL 3 months after surgery.</p> <p><strong>Results:&nbsp;</strong>The multiple regression shows that EuroSCORE, length of endotracheal intubation, and anxiety symptoms predict LOS. The multiple quantile regression analyses also show that both symptoms of anxiety and depression predict a negative HRQoL up to 3 months after surgery.</p> <p><strong>Conclusion:&nbsp;</strong>Preoperative symptoms of anxiety predict the patients&#39; LOS, and both symptoms of anxiety and depression predict a scarce HRQoL 3 months after cardiac surgery. These results suggest the need for implementing presurgical in-hospital screening procedures for both symptoms of anxiety and depression. Finally, focused psychological interventions should be implemented for reducing inpatients&#39; hospital LOS and improving their future quality of life.</p>

restrictedJul 2021View details →
zenodo12/100

Dataset related to article: "Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy"

<p>We provide the raw data used for the following article:</p> <ul> <li>Magri F, Chytiris S, Molteni M, Croce L, Coperchini F, Rotondi M, Fonte R, Chiovato L.<br> <em>Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy.</em><br> &quot;J Endocrinol Invest&quot;. 2020 Jan;43(1):95-100. doi: 10.1007/s40618-019-01085-8. Epub 2019 Jul 18. PMID: 31321758</li> </ul> <p>&nbsp;</p> <p><strong>Abstract</strong><br> <strong>Purpose: </strong> The aim of the present study was to retrospectively evaluate the efficacy of interstitial laser photocoagulation (ILP) ablation of thyroid nodules during a 6-year follow-up period and to identify possible predictors of the final outcome.<br> <strong>Methods: </strong> Forty-three outpatients (38 women) were assigned to ILP therapy. The study group included euthyroid patients with benign thyroid nodules. Thyroid size, nodule volume and features, and autoimmune test were collected at baseline. Patients underwent US control after the ILP procedure and 1 month, 6 months, 12 months later and then annually.<br> <strong>Results: </strong> During the follow-up, two distinct groups of patients emerged: the responders (N = 33) and the non-responder (N = 10) ones to ILP. In the responder group, the nodule volume significantly decreased during the follow-up, but a trend toward a slight increase in nodule volume was recorded up to the end of follow-up. No significant decrease in nodule volume was observed in the non-responder group. Neither baseline clinical nor demographic features were significantly different between responders and non-responders groups. In the whole group of patients, the energy delivered per mL of nodule tissue was significantly correlated with the percent volume decrease at the end of follow-up.<br> <strong>Conclusions: </strong> Interstitial laser photocoagulation is a safe technique able to reduce byabout 50% the volume of benign thyroid nodules in the majority of treated patients. However, due to the great variability of results, an active follow-up is required. The only independent predictor of ILP outcome is the energy delivered per mL of nodule tissue.</p>

restrictedSep 2021View details →
zenodo12/100

Dataset related to article "Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)"

<p>This record contains raw data related to article &ldquo;Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)&quot;</p> <p>&nbsp;</p> <p>Abstract:</p> <p>Psoriasis is one of the commonest inflammatory skin diseases determining a very high impact on patients&#39; quality of life and daily activities and relationships. Several biologic therapies have been approved through the years for the treatment of moderate-to-severe plaque psoriasis, and efficacy and safety profile have been analyzed in clinical trials. Ixekizumab is an immunoglobulin G subclass 4 monoclonal antibody that selectively targets and binds IL-17A with high specificity and affinity. Inhibiting IL-17A activity, ixekizumab reduces and turns down levels of inflammation, resulting in the clinical improvement of the disease. Long-term efficacy and safety profile of ixekizumab have been investigated and reported in the UNCOVER trials, but in literature there are only few studies based on real life experience. We present the efficacy and safety profile of ixekizumab in a cohort of 779 patients affected by moderate-to-severe plaque psoriasis and treated with ixekizumab in 11 Italian dermatology hospitals, with a follow-up of care until 192 weeks.</p>

restrictedNov 2022View details →
zenodo12/100

Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial

<p>Gaudino M, Castelvecchio S, Rahouma M, Robinson NB, Audisio K, Soletti GJ, Cancelli G, Tam DY, Garatti A, Benedetto U, Doenst T, Girardi LN, Michler RE, Fremes SE, Velazquez EJ, Menicanti L. Long-term results of surgical ventricular reconstruction and comparison with the Surgical Treatment for Ischemic Heart Failure trial. J Thorac Cardiovasc Surg. 2022 Apr 26:S0022-5223(22)00493-7. doi: 10.1016/j.jtcvs.2022.04.016. Epub ahead of print. PMID: 35599207.</p> <p><strong>Abstract</strong></p> <p><strong>Objective:&nbsp;</strong>The role of surgical ventricular reconstruction (SVR) in patients with ischemic cardiomyopathy is controversial. Observational series and the Surgical Treatment of IsChemic Heart failure (STICH) trial reported contradictory results. SVR is highly dependent on operator experience. The aim of this study is to compare the long-term results of SVR between a high-volume SVR institution and the STICH trial using individual patient data.</p> <p><strong>Methods:&nbsp;</strong>Patients undergoing SVR at San Donato Hospital (Milan) were compared with patients undergoing SVR in STICH (as-treated principle) by inverse probability treatment-weighted Cox regression. The primary outcome was all-cause mortality.</p> <p><strong>Results:&nbsp;</strong>The San Donato cohort included 725 patients, whereas the STICH cohort included 501. Compared with the STICH-SVR cohort, San Donato patients were older (66.0, lower quartile, upper quartile [Q1, Q3: 58.0, 72.0] vs 61.9 [Q1, Q3: 55.1, 68.8], P &lt; .001) and with lower left ventricular end-systolic volume index at baseline (LVESVI: 77.0 [Q1, Q3: 59.0, 97.0] vs 80.8 [Q1, Q3: 58.5, 106.8], P = .02). Propensity score weighting yielded 2 similar cohorts. At 4-year follow-up, mortality was significantly lower in the San Donato cohort compared with the STICH-SVR cohort (adjusted hazard ratio, 0.71; 95% confidence interval, 0.53-0.95; P = .001). Greater postoperative LVESVI was independently associated with mortality (hazard ratio, 1.02; 95% confidence interval, 1.01-1.03). At 4 to 6 months of follow-up, the mean reduction of LVESVI in the San Donato cohort was 39.6%, versus 10.7% in the STICH-SVR cohort (P &lt; .001).</p> <p><strong>Conclusions:&nbsp;</strong>Patients with postinfarction LV remodeling undergoing SVR at a high-volume SVR institution had better long-term results than those reported in the STICH trial, suggesting that a new trial testing the SVR hypothesis may be warranted.</p>

restrictedJan 2023View details →
zenodo12/100

Beating Versus Arrested Heart Isolated Tricuspid Valve Surgery: Long-term Outcomes

<p>Russo M, Di Mauro M, Saitto G, Lio A, Berretta P, Taramasso M, Scrofani R, Della Corte A, Sponga S, Greco E, Saccocci M, Calafiore A, Bianchi G, Leviner DB, Biondi A, Della Ratta E, Livi U, Sharoni E, Werner P, De Vincentiis C, Di Eusanio M, Kocher A, Antona C, Miraldi F, Troise G, Solinas M, Maisano F, Laufer G, Musumeci F, Andreas M. Beating Versus Arrested Heart Isolated Tricuspid Valve Surgery: Long-term Outcomes. Ann Thorac Surg. 2022 Feb;113(2):585-592. doi: 10.1016/j.athoracsur.2021.03.070. Epub 2021 Apr 5. PMID: 33831392.</p> <p>Abstract</p> <p><strong>Background:&nbsp;</strong>Isolated tricuspid valve (TV) surgery is a rare procedure generally considered at high risk for perioperative mortality and poor long-term outcomes. Surgical treatment can be performed with either an arrested heart (AH) or beating heart (BH) technique. The aim of this study was to compare the outcomes of isolated tricuspid surgery with 2 different approaches.</p> <p><strong>Methods:&nbsp;</strong>The Surgical-Tricuspid Study is a multicenter international retrospective study enrolling adult patients who underwent isolated TV procedures (n = 406; age 56 &plusmn; 16 years; 56% female) at 13 international sites. The AH and BH strategies were performed in 253 and 153 patients, respectively. Propensity score-matched analysis was used to compare groups.</p> <p><strong>Results:&nbsp;</strong>After matching, 129 pairs were obtained and analyzed. The 30-day mortality rate was 6.2% versus 5.0% in the AH and BH groups, respectively (P = .9). The rates of acute renal failure requiring replacement therapy (10% versus 3%; P = .02) and stroke (1.6% versus 0%; P = .08) were numerically higher in the AH group. The 6-year survival rate was 67% &plusmn; 6% versus 78% &plusmn; 5% in the AH and BH groups, respectively (P = .18), whereas freedom from cardiac death was 75% &plusmn; 5% versus 84% &plusmn; 4% (P = .21). The 6-year composite cardiac end point of cardiac death and reoperation rate was 60% &plusmn; 9% versus 86% &plusmn; 5% (P = .024) comparing AH-TV replacement and BH-TV repair groups.</p> <p><strong>Conclusions:&nbsp;</strong>Isolated TV surgery performed with a BH strategy is a safe option and resulted in a trend of increased long-term survival and freedom from reoperation compared with the standard AH technique. Patients undergoing BH valve repair had the best long-term outcome.</p>

restrictedFeb 2023View details →
zenodo12/100

Dataset related to article "Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer"

<p>This record contains raw data related to article &ldquo;Predictors of fulvestrant long-term benefit in hormone receptor-positive/HER2 negative advanced breast cancer&quot;</p> <p>Abstract</p> <p>We retrospectively investigated in women treated with fulvestrant for HR+/HER2 negative advanced breast cancer clinical, pathological and molecular features associated with long-term benefit from treatment defined as being progression-free at 18 months. Specifically, we analyzed on formalin-fixed paraffin-embedded tumor samples ESR1 and PI3KCA mutations and miRNAs profiles. 59 patients were evaluable (median age of 67 years, range 32-92). 18-month PFS rate was 27%; the lack of visceral metastases significantly predicted the likelihood of being progression-free at 18 months, while PI3KCA mutations, found in 36% of patients, were not associated with 18-month PFS. As of miRNAs, miR-549a, miR-644a, miR-16-5p were negatively while let-7c-5p was positively associated with 18-month PFS. In addition, miR-520d-3p and miR-548g-3p values were significantly lower while miR-603, miR-181a-5p and miR-199a-miR-199b-3p values were significantly higher in patients achieving 18-month PFS. In silico analysis of targets modulated by these two latter groups of miRNAs show that in patients achieving 18-month PFS the Hippo and Wnt signaling pathways were predicted to be upregulated while endocrine resistance was potentially repressed by miR-603, miR-181a-5p and miR-199a-miR-199b-3p. Our results provide additional clues on the molecular mechanisms involved in fulvestrant activity and resistance. Underlying pathways should be further elucidated and confirmed in larger cohorts</p>

restrictedFeb 2023View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.